Institutional Ownership Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN). We have compiled data on the 10 institutions that hold shares in the stock, with a total of 245,531 shares, which have been reported (via 13F filing form) to have a value of $287,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Cantor Fitzgerald, L. P.
New York, NY |
Nov 14, 2024 Q3 2024 |
79,492
shares
|
$93,005
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
45,996
shares
|
$53,815
0.0% of portfolio
|
Q3 2024
Added 40.88%
|
|
|
Meitav Dash Investments LTD
|
Feb 03, 2025 Q4 2024 |
40,000
shares
|
$46,800
0.0% of portfolio
|
Q2 2024
Reduced 20.0%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
34,280
shares
|
$40,107
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Stratos Wealth Partners, Ltd.
|
Jan 27, 2025 Q4 2024 |
20,000
shares
|
$23,400
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Commonwealth Equity Services, LLC
|
Oct 18, 2024 Q3 2024 |
12,625
shares
|
$14,771
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
11,963
shares
|
$13,996
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Cwm, LLC
|
Feb 04, 2025 Q4 2024 |
1,000
shares
|
$1,170
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Feb 05, 2025 Q4 2024 |
175
shares
|
$204
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|